258 related articles for article (PubMed ID: 31923638)
1. Colorectal screening using the immunochemical faecal occult blood test kit among the Malaysian cohort participants.
Abdullah N; Abd Jalal N; Ismail N; Kamaruddin MA; Abd Mutalib NS; Alias MR; Mazlan L; Sagap I; Jamal R
Cancer Epidemiol; 2020 Apr; 65():101656. PubMed ID: 31923638
[TBL] [Abstract][Full Text] [Related]
2. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer screening: comparison of transferrin and immuno fecal occult blood test.
Chen JG; Cai J; Wu HL; Xu H; Zhang YX; Chen C; Wang Q; Xu J; Yuan XL
World J Gastroenterol; 2012 Jun; 18(21):2682-8. PubMed ID: 22690078
[TBL] [Abstract][Full Text] [Related]
4. The factors associated with negative colonoscopy in screening subjects with positive immunochemical stool occult blood test outcomes.
Ting PH; Lin XH; Jiang JK; Luo JC; Chen PH; Wang YP; Hsin IF; Perng CL; Hou MC; Lee FY
J Chin Med Assoc; 2018 Sep; 81(9):759-765. PubMed ID: 29778550
[TBL] [Abstract][Full Text] [Related]
5. Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort.
Chen LS; Yen AM; Chiu SY; Liao CS; Chen HH
Lancet Oncol; 2011 Jun; 12(6):551-8. PubMed ID: 21592859
[TBL] [Abstract][Full Text] [Related]
6. Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design.
Juul JS; Bro F; Hornung N; Andersen BS; Laurberg S; Olesen F; Vedsted P
BMC Cancer; 2016 Jul; 16():445. PubMed ID: 27400657
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of immunochemical faecal occult blood testing for colorectal cancer screening in Bulgaria.
Tsvetanova Dimova R; Dimitrova Dimitrova D; Angelova Levterova B; Stoyanov Dimov R; Atanasova Semerdjieva M; Frantova Tarnovska M; Gencheva Stoyanova R
J BUON; 2015; 20(2):413-20. PubMed ID: 26011330
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a Colorectal Carcinoma Screening Program in Kota Setar and Kuala Muda Districts, Malaysia.
Abu Hassan MR; Leong TW; Othman Andu DF; Hat H; Nik Mustapha NR
Asian Pac J Cancer Prev; 2016; 17(2):569-73. PubMed ID: 26925645
[TBL] [Abstract][Full Text] [Related]
9. Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; Jansen JB; Verbeek AL; Dekker E
Br J Cancer; 2009 Oct; 101(8):1274-81. PubMed ID: 19755997
[TBL] [Abstract][Full Text] [Related]
10. Rate and associated factors of refusal to perform immunochemical Faecal Occult Blood Test (iFOBT) among semi-urban communities.
Syed Soffian SS; Safian N; Nawi AM; Ahmad SB; Chan HK; Abu Hassan MR
PLoS One; 2021; 16(10):e0258129. PubMed ID: 34618854
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the immunofecal occult blood test for colorectal cancer screening in a large population.
Yang H; Ge Z; Dai J; Li X; Gao Y
Dig Dis Sci; 2011 Jan; 56(1):203-7. PubMed ID: 20458621
[TBL] [Abstract][Full Text] [Related]
12. A 5-year evaluation of using stool-based test for opportunistic colorectal cancer screening in primary health institutions across Malaysia.
Tamin NSI; Razalli KA; Sallahuddin SN; Chan HK; Hassan MRA
Cancer Epidemiol; 2020 Dec; 69():101829. PubMed ID: 32998070
[TBL] [Abstract][Full Text] [Related]
13. Overview of colorectal cancer screening programme in Malaysia.
Arunah C; Feisul IM; Nor Saleha IT; Muhammad Radzi AH
Med J Malaysia; 2020 May; 75(3):235-239. PubMed ID: 32467538
[TBL] [Abstract][Full Text] [Related]
14. A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
Dig Liver Dis; 2018 Mar; 50(3):254-259. PubMed ID: 29198569
[TBL] [Abstract][Full Text] [Related]
15. Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.
Wieten E; de Klerk CM; van der Steen A; Ramakers CR; Kuipers EJ; Hansen BE; Lansdorp-Vogelaar I; Bossuyt PM; Dekker E; Spaander MCW
Gastroenterology; 2018 Nov; 155(5):1392-1399.e5. PubMed ID: 30055170
[TBL] [Abstract][Full Text] [Related]
16. Systematic review with meta-analysis: faecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies.
Hirai HW; Tsoi KK; Chan JY; Wong SH; Ching JY; Wong MC; Wu JC; Chan FK; Sung JJ; Ng SC
Aliment Pharmacol Ther; 2016 Apr; 43(7):755-64. PubMed ID: 26858128
[TBL] [Abstract][Full Text] [Related]
17. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
Kelley L; Swan N; Hughes DJ
Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
[TBL] [Abstract][Full Text] [Related]
18. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.
Dominitz JA; Robertson DJ; Ahnen DJ; Allison JE; Antonelli M; Boardman KD; Ciarleglio M; Del Curto BJ; Huang GD; Imperiale TF; Larson MF; Lieberman D; O'Connor T; O'Leary TJ; Peduzzi P; Provenzale D; Shaukat A; Sultan S; Voorhees A; Wallace R; Guarino PD
Am J Gastroenterol; 2017 Nov; 112(11):1736-1746. PubMed ID: 29016565
[TBL] [Abstract][Full Text] [Related]
19. KRAS mutations and M2PK upregulation in stool samples from individuals with positive fecal occult blood tests screened for colorectal cancer.
Battaglia P; Baritono E; Remo A; Vendraminelli R; Conti A
Tumori; 2014; 100(2):122-7. PubMed ID: 24852854
[TBL] [Abstract][Full Text] [Related]
20. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.
Peng SM; Hsu WF; Wang YW; Lin LJ; Yen AM; Chen LS; Lee YC; Wu MS; Chen TH; Chiu HM
Gut; 2021 Jul; 70(7):1318-1324. PubMed ID: 32989019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
